INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q1 2022
Shares 17,258 Value ($000) $281 Avg Close — Range —
Q4 2021
Shares 22,035 Value ($000) $359 Avg Close — Range —
Q3 2021
Shares 79,145 Value ($000) $1,175 Avg Close — Range —
Q3 2019
Shares 7,199 Value ($000) $478 Avg Close — Range —
Q3 2017
Shares 12,596 Value ($000) $731 Avg Close — Range —
Q3 2015
Shares 4,265 Value ($000) $707 Avg Close — Range —
Q2 2015
Shares 1,075 Value ($000) $259 Avg Close — Range —
Q3 2014
Shares 19,412 Value ($000) $4,595 Avg Close — Range —
Q2 2014
Shares 3,615 Value ($000) $855 Avg Close — Range —
Q1 2014
Shares 3,534 Value ($000) $1,165 Avg Close — Range —